Stockreport

Provectus Biopharmaceuticals Launches VisiRose, Provectus's Founded Entity for Pharmaceutical-grade Rose Bengal Sodium-based Treatments in Ophthalmology [Yahoo! Finance]

PROVECTUS BIOPHARMS  (PVCT) 
NASDAQ:AMEX Investor Relations: provectusbio.com/financial-overview
PDF the launch of VisiRose, Inc. (“VisiRose”), Provectus's first Founded Entity. This new clinical-stage biotechnology company is focused on commercializing Rose Bengal Phot [Read more]